Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Clinical  ·  Weekly Digest - 11 July to 17 July 2026
Hansoh Pharma announces ARTEMIS-008 trial achieved primary OS endpoint in SCLC

Weekly Digest – July 2026 Weekly Digest – July 2026 10 July 2026: Hansoh Pharma announces ARTEMIS-008 trial achieved primary OS endpoint in SCLC Hansoh Pharma announced that its B7-H3-targeted antibody-drug conjugate Risvutatug rezetecan met the primary endpoint of overall […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 11 July to 17 July 2026
Kelun-Biotech’s phase 3 trial of Sac-TMT plus Pembrolizumab met the primary endpoint in 1L PD-L1-negative non-squamous NSCLC

Weekly Digest – July 2026 Weekly Digest – July 2026 15 July 2026: Kelun-Biotech’s phase 3 trial of Sac-TMT plus Pembrolizumab met the primary endpoint in 1L PD-L1-negative non-squamous NSCLC Kelun-Biotech announced that its TROP2-targeted antibody-drug conjugate Sacituzumab tirumotecan, in […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 11 July to 17 July 2026
VERAXA Biotech and Ardigen collaborate to accelerate AI-enabled BiTAC pipeline development

Weekly Digest – July 2026 Weekly Digest – July 2026 13 July 2026: VERAXA Biotech and Ardigen collaborate to accelerate AI-enabled BiTAC  pipeline development VERAXA Biotech has entered an AI-enabled drug discovery collaboration with Ardigen to accelerate the development of […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 11 July to 17 July 2026
Protina partners with Onconic Therapeutics on next-generation cancer drugs

Weekly Digest – July 2026 Weekly Digest – July 2026 15 July 2026: Protina partners with Onconic Therapeutics on next-generation cancer drugs Proteina and Onconic Therapeutics have entered a strategic collaboration to develop next-generation oncology therapies, combining Proteina’s antibody engineering […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 04 July to 10 July
China’s NMPA administration accepts Biologics License Application for PADCEV plus Keytruda in Muscle-Invasive Bladder Cancer

Weekly Digest – July 2026 Weekly Digest – July 2026 7 July 2026: China’s NMPA administration accepts Biologics License Application for PADCEV plus Keytruda in Muscle-Invasive Bladder Cancer Astellas have announced that China’s National Medical Products Administration has accepted the […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 04 July to 10 July
Hengrui ADC innovative drug Ruikang Trastuzumab new indication marketing application accepted and included in priority review

Weekly Digest – July 2026 Weekly Digest – July 2026 8 July 2026: Hengrui ADC innovative drug Ruikang Trastuzumab new indication marketing application accepted and included in priority review Hengrui Pharma’s HER2-targeted antibody-drug conjugate Trastuzumab rezetecan has had its new […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 04 July to 10 July
InnoCare Pharma announced that the first patient dosing in the clinical trial of ICP-B208, its novel ADC targeting CDH17

Weekly Digest – July 2026 Weekly Digest – July 2026 6 July 2026: InnoCare Pharma announced that the first patient dosing in the clinical trial of ICP-B208, its novel ADC targeting CDH17 InnoCare Pharma has announced the successful first patient […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 04 July to 10 July
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Weekly Digest – July 2026 Weekly Digest – July 2026 06 July 2026: Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients Novartis has agreed to acquire Myricx […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 04 July to 10 July
Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development

Weekly Digest – July 2026 Weekly Digest – July 2026 7 July 2026: Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development Biocytogen and Whitehawk Therapeutics have entered a global collaboration to develop next-generation bispecific antibody-drug conjugates, […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest -04 July to 10 July
Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development

Weekly Digest – July 2026 Weekly Digest – July 2026 29 June 2026: Enhertu approved in the EU as the first tumor-agnostic HER2-targeted ADC for previously treated HER2 positive metastatic Solid tumors The European Union has approved Enhertu as the […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous8910111213141516Next ›Last »
Page 12 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id